Stay updated with breaking news from Stevenh Stein. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Repare Therapeutics Inc. , a leading clinical-stage precision oncology company, today announced the appointment of Steven H. Stein, M.D., to its Board of Directors, effective as of the date of the...
Repare Therapeutics Inc. ("Repare" or the "Company") , a leading clinical-stage precision oncology company, today announced the appointment of Steven H. Stein, M.D., to its Board of Directors, effective as of the date of the Company's upcoming annual...
Xponance Inc. boosted its position in Incyte Co. (NASDAQ:INCY – Get Rating) by 8.5% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 38,946 shares of the biopharmaceutical company’s stock after purchasing an additional 3,050 shares during the period. Xponance […]
Pacer Advisors Inc. decreased its position in Incyte Co. (NASDAQ:INCY – Get Rating) by 92.3% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 666 shares of the biopharmaceutical company’s stock after selling 7,945 shares during the quarter. Pacer Advisors Inc.’s holdings in Incyte were […]
JMP Securities reissued their market outperform rating on shares of Incyte (NASDAQ:INCY – Get Rating) in a report released on Tuesday, Benzinga reports. JMP Securities currently has a $113.00 target price on the biopharmaceutical company’s stock. A number of other analysts also recently commented on the stock. Wells Fargo & Company boosted their price target […]